Organization · Venture Capital
THENA Capital
THENA Capital is a London-based venture capital firm that invests in early-stage medtech companies, particularly those addressing women's health, oncology, and mental health. The firm supports UK startups aiming for global market expansion, especially in the US.
Overview
What THENA Capital does
What THENA Capital is
THENA Capital is a London-based venture capital firm that invests in early-stage medtech companies, particularly those addressing women's health, oncology, and mental health. The firm supports UK startups aiming for global market expansion, especially in the US.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find THENA Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
THENA Capital as a funder
Investment thesis
Backing UK-based early-stage medical technology companies addressing unmet clinical needs, with particular focus on women's health, oncology, and mental health. The fund organizes investments across three pillars: patient support, care delivery, and medical products.
Focus narrative
THENA Capital invests in digital health platforms and fast-track medical technologies, specifically targeting early-stage companies with clear commercial momentum. The firm emphasizes investments in sectors addressing chronic conditions, women's health, oncology, mental health, and care delivery, seeking to partner with companies that have global ambitions.
Value beyond capital
THENA Capital provides strategic support to portfolio companies, helping them navigate regulatory pathways and expand into international markets, particularly the US. The firm leverages its team's extensive experience in medical device commercialization and digital health to enhance the growth and impact of its investments.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- United Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Notable portfolio companies include Daye, which offers CBD-infused menstrual health products and digital gynecological care; Samphire Neuroscience, known for its wearable pain relief technology for women; MyMynd, a digital behavioral health platform; and Plexaa, a wound healing platform.
Common questions
What to know about THENA Capital
Upseed classifies THENA Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.